Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of PSMA-PET-guided CT-based radiomic signature to predict biochemical recurrence after salvage radiotherapy.
Spohn SKB, Schmidt-Hegemann NS, Ruf J, Mix M, Benndorf M, Bamberg F, Makowski MR, Kirste S, Rühle A, Nouvel J, Sprave T, Vogel MME, Galitsnaya P, Gschwend JE, Gratzke C, Stief C, Löck S, Zwanenburg A, Trapp C, Bernhardt D, Nekolla SG, Li M, Belka C, Combs SE, Eiber M, Unterrainer L, Unterrainer M, Bartenstein P, Grosu AL, Zamboglou C, Peeken JC. Spohn SKB, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2537-2547. doi: 10.1007/s00259-023-06195-3. Epub 2023 Mar 16. Eur J Nucl Med Mol Imaging. 2023. PMID: 36929180 Free PMC article.
Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy-a multicenter retrospective study.
Schmidt-Hegemann NS, Kroeze SGC, Henkenberens C, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Müller AC, Grosu AL, Combs SE, Christiansen H, Guckenberger M, Belka C. Schmidt-Hegemann NS, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1852-1863. doi: 10.1007/s00259-020-04708-y. Epub 2020 Jan 30. Eur J Nucl Med Mol Imaging. 2020. PMID: 32002591
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Vogel MME, Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Mix M, la Fougère C, Eiber M, Christiansen H, Belka C, Grosu AL, Müller AC, Guckenberger M, Combs SE. Vogel MME, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2328-2338. doi: 10.1007/s00259-020-04760-8. Epub 2020 Mar 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 32179961 Free PMC article.
Uncovering the invisible-prevalence, characteristics, and radiomics feature-based detection of visually undetectable intraprostatic tumor lesions in 68GaPSMA-11 PET images of patients with primary prostate cancer.
Zamboglou C, Bettermann AS, Gratzke C, Mix M, Ruf J, Kiefer S, Jilg CA, Benndorf M, Spohn S, Fassbender TF, Bronsert P, Chen M, Guo H, Wang F, Qiu X, Grosu AL. Zamboglou C, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1987-1997. doi: 10.1007/s00259-020-05111-3. Epub 2020 Nov 18. Eur J Nucl Med Mol Imaging. 2021. PMID: 33210239 Free PMC article.
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis.
Spohn SKB, Farolfi A, Schandeler S, Vogel MME, Ruf J, Mix M, Kirste S, Ceci F, Fanti S, Lanzafame H, Serani F, Gratzke C, Sigle A, Combs SE, Bernhardt D, Gschwend JE, Buchner JA, Trapp C, Belka C, Bartenstein P, Unterrainer L, Unterrainer M, Eiber M, Nekolla SG, Schiller K, Grosu AL, Schmidt-Hegemann NS, Zamboglou C, Peeken JC. Spohn SKB, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):218-227. doi: 10.1007/s00259-022-05931-5. Epub 2022 Aug 19. Eur J Nucl Med Mol Imaging. 2022. PMID: 35984452 Free PMC article.
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation.
Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Christiansen H, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M. Kroeze SGC, et al. Among authors: mix m. Eur Urol Focus. 2021 Mar;7(2):309-316. doi: 10.1016/j.euf.2019.08.012. Epub 2019 Sep 5. Eur Urol Focus. 2021. PMID: 31495759
Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.
Oehus AK, Kroeze SGC, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M, Christiansen H, Henkenberens C. Oehus AK, et al. Among authors: mix m. BMC Cancer. 2020 Apr 29;20(1):362. doi: 10.1186/s12885-020-06883-5. BMC Cancer. 2020. PMID: 32349700 Free PMC article.
Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D, Fechter T, Bartl N, Grosu AL, Gratzke C, Sigle A, Mix M, Ruf J, Fassbender TF, Kiefer S, Bettermann AS, Nicolay NH, Spohn S, Kramer MU, Bronsert P, Guo H, Qiu X, Wang F, Henkenberens C, Werner RA, Baltas D, Meyer PT, Derlin T, Chen M, Zamboglou C. Kostyszyn D, et al. Among authors: mix m. J Nucl Med. 2021 Jun 1;62(6):823-828. doi: 10.2967/jnumed.120.254623. Epub 2020 Oct 30. J Nucl Med. 2021. PMID: 33127624 Free PMC article.
Interleukin-6 as surrogate marker for imaging-based hypoxia dynamics in patients with head-and-neck cancers undergoing definitive chemoradiation-results from a prospective pilot trial.
Rühle A, Wiedenmann N, Fennell JT, Mix M, Ruf J, Stoian R, Thomsen AR, Vaupel P, Baltas D, Grosu AL, Nicolay NH. Rühle A, et al. Among authors: mix m. Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1650-1660. doi: 10.1007/s00259-021-05602-x. Epub 2021 Nov 13. Eur J Nucl Med Mol Imaging. 2022. PMID: 34773163 Free PMC article. Clinical Trial.
176 results